184 related articles for article (PubMed ID: 24473688)
41. A new patient with hyperornithinaemia, hyperammonaemia and homocitrullinuria treated early with low protein diet.
Gjessing LR; Lunde HA; Undrum T; Broch H; Alme A; Lie SO
J Inherit Metab Dis; 1986; 9(2):186-92. PubMed ID: 3091924
[TBL] [Abstract][Full Text] [Related]
42. [Clinical and laboratory screening studies on urea cycle defects].
Yang YL; Sun F; Qian N; Song JQ; Wang S; Chang XZ; Yang HY; Wang SQ; Li L; Zhang YH; Bao XH; Li M; Qi Y; Qin J; Wu XR
Zhonghua Er Ke Za Zhi; 2005 May; 43(5):331-4. PubMed ID: 15924745
[TBL] [Abstract][Full Text] [Related]
43. Efficacy of peritoneal dialysis in neonates presenting with hyperammonaemia due to urea cycle defects and organic acidaemia.
Celik M; Akdeniz O; Ozgun N
Nephrology (Carlton); 2019 Mar; 24(3):330-335. PubMed ID: 29356227
[TBL] [Abstract][Full Text] [Related]
44. Retinal risks of high-dose ornithine supplements: a review.
Hayasaka S; Kodama T; Ohira A
Br J Nutr; 2011 Sep; 106(6):801-11. PubMed ID: 21767450
[TBL] [Abstract][Full Text] [Related]
45. A rare urea cycle disorder in a neonate: N-acetylglutamate synthetase deficiency.
Olgac A; Kasapkara ÇS; Kilic M; Emine Derinkuyu B; Azapagasi E; Kesici S; Biberoğlu G; Ozyazici A; Karaca M; Haberle J
Arch Argent Pediatr; 2020 Dec; 118(6):e545-e548. PubMed ID: 33231058
[TBL] [Abstract][Full Text] [Related]
46. Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome (HHH) presenting with acute fulminant hepatic failure.
Mhanni AA; Chan A; Collison M; Seifert B; Lehotay DC; Sokoro A; Huynh HQ; Greenberg CR
J Pediatr Gastroenterol Nutr; 2008 Mar; 46(3):312-5. PubMed ID: 18376250
[TBL] [Abstract][Full Text] [Related]
47. Hyperornithinemia, hyperammonemia, and homocitrullinuria syndrome with evidence of mitochondrial dysfunction due to a novel SLC25A15 (ORNT1) gene mutation in a Palestinian family.
Korman SH; Kanazawa N; Abu-Libdeh B; Gutman A; Tsujino S
J Neurol Sci; 2004 Mar; 218(1-2):53-8. PubMed ID: 14759633
[TBL] [Abstract][Full Text] [Related]
48. Molecular diagnosis for a fatal case of very long-chain acyl-CoA dehydrogenase deficiency in Hong Kong Chinese with a novel mutation: a preventable death by newborn screening.
Siu WK; Mak CM; Siu SL; Siu TS; Pang CY; Lam CW; Kwong NS; Chan AY
Diagn Mol Pathol; 2012 Sep; 21(3):184-7. PubMed ID: 22847164
[TBL] [Abstract][Full Text] [Related]
49. A novel R275X mutation of the SLC25A15 gene in a Japanese patient with the HHH syndrome.
Torisu H; Kira R; Kanazawa N; Takemoto M; Sanefuji M; Sakai Y; Tsujino S; Hara T
Brain Dev; 2006 Jun; 28(5):332-5. PubMed ID: 16376511
[TBL] [Abstract][Full Text] [Related]
50. Urea cycle disorders: clinical presentation outside the newborn period.
Smith W; Kishnani PS; Lee B; Singh RH; Rhead WJ; Sniderman King L; Smith M; Summar M
Crit Care Clin; 2005 Oct; 21(4 Suppl):S9-17. PubMed ID: 16227115
[TBL] [Abstract][Full Text] [Related]
51. Molecular diagnosis of urea cycle disorders: current global scenario.
Vaidyanathan K
Indian J Biochem Biophys; 2013 Oct; 50(5):357-62. PubMed ID: 24772957
[TBL] [Abstract][Full Text] [Related]
52. [Neonatal hyperammonemia].
Jaeken J; Devlieger H; Evens M; Casaer P; Eggermont E
Tijdschr Kindergeneeskd; 1983 Jun; 51(3):101-4. PubMed ID: 6636106
[TBL] [Abstract][Full Text] [Related]
53. Seven novel mutations in the ORNT1 gene (SLC25A15) in patients with hyperornithinemia, hyperammonemia, and homocitrullinuria syndrome.
Salvi S; Dionisi-Vici C; Bertini E; Verardo M; Santorelli FM
Hum Mutat; 2001 Nov; 18(5):460. PubMed ID: 11668643
[TBL] [Abstract][Full Text] [Related]
54. Hyperammonaemia in Neonates and Young Children: Potential Metabolic Causes, Diagnostic Approaches and Clinical Consequences.
Giva S; Finnegan J; Ihidero P; Maguire G; Power B; Knerr I; Monavari A
Ir Med J; 2019 Jan; 112(1):858. PubMed ID: 30719899
[TBL] [Abstract][Full Text] [Related]
55. Biochemical and molecular characteristics of patients with organic acidaemias and urea cycle disorders identified through newborn screening.
Barends M; Pitt J; Morrissy S; Tzanakos N; Boneh A;
Mol Genet Metab; 2014; 113(1-2):46-52. PubMed ID: 25047749
[TBL] [Abstract][Full Text] [Related]
56. Defective ornithine metabolism in the syndrome of hyperornithinaemia, hyperammonaemia and homocitrullinuria.
Shih VE; Mandell R; Herzfeld A
J Inherit Metab Dis; 1981; 4(2):95-6. PubMed ID: 6790865
[No Abstract] [Full Text] [Related]
57. Studies on the pathway from ornithine to proline in cultured skin fibroblasts with reference to the defect in hyperornithinaemia with hyperammonaemia and homocitrullinuria.
Gray RG; Hill SE; Pollitt RJ
J Inherit Metab Dis; 1983; 6(4):143-8. PubMed ID: 6422153
[TBL] [Abstract][Full Text] [Related]
58. Studies on a case of HHH-syndrome (hyperammonemia, hyperornithinemia, homocitrullinuria).
Hommes FA; Roesel RA; Metoki K; Hartlage PL; Dyken PR
Neuropediatrics; 1986 Feb; 17(1):48-52. PubMed ID: 3960284
[TBL] [Abstract][Full Text] [Related]
59. [Hyperammonemia type II as an example of urea cycle disorder].
Hawrot-Kawecka AM; Kawecki GP; Duława J
Wiad Lek; 2006; 59(7-8):512-5. PubMed ID: 17209350
[TBL] [Abstract][Full Text] [Related]
60. Coma, hyperammonemia, metabolic acidosis, and mutation: lessons learned in the acute management of late onset urea cycle disorders.
Iyer H; Sen M; Prasad C; Rupar CA; Lindsay RM
Hemodial Int; 2012 Jan; 16(1):95-100. PubMed ID: 22099885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
